PharmEasy parent API Holdings pulls IPO, pivots to rights issue for growth funding
API Holdings withdrew its DRHP filed November 9, 2021, citing adverse market conditions. The online pharmacy parent now plans a rights issue opening early September 2022 to fund expansion, signaling continued capital strain across digital health retail.
API Holdings, parent of online pharmacy PharmEasy, withdrew its IPO DRHP citing market conditions, and plans a rights issue opening early September 2022 to fund growth and expansion plans.